Tag: Biologics
Hand Eczema Market to Reach USD 29.2 Billion by 2035, Impelled by the Development of New and More Effective Treatments, Including Biologics, Corticosteroids, and Topical Therapies – BioSpace
eczemarelief
February 1, 2025
Abrocitinib Effective for Atopic Dermatitis Patients Unresponsive to Biologics
eczemarelief
June 20, 2024
IL-23 inhibitors may have a lower risk of paradoxical eczema in comparison to other biologics
eczemarelief
January 26, 2024
Alphyn Biologics Presents New Data from Phase 2a Trial Showing Significant Improvement of Mild-to-Moderate Atopic Dermatitis
eczemarelief
July 10, 2023